Conference Coverage

ONS Annual Congress


2015    2014   2013   2012   2011






ASCO


2015  2014



Recent Conference Coverage

Managing oral oncology/hematology treatments in your practice

An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.

Growing up with cancer: Understanding the challenges to adolescents and young adults (AYAs) coping with cancer

DENVER, CO—The emotional trajectory of the cancer experience compounds the emotional pendulum adolescents and young adults (AYAs) are already experiencing as their cognition, hormones, and emotions mature. Delivery of high-quality cancer care for these patients requires understanding the behavior, social, and environmental context of their lives, according to a presentation at the 2015 Oncology Nurse Advisor Navigation Summit.

Navigators have a key role in using genetics and genomics for cancer risk identification

DENVER, CO—The nurse navigator's role in cancer risk identification is three-fold. Despite the changes brought on by genetic/genomics, aspects of the nursing role are consistent with the essential competencies required of all professional nurses, according to a presentation at the 2015 Oncology Nurse Advisor Navigation Summit.

Composing a CoC-compliant community health needs assessment (CHNA)

DENVER, CO—Initial reactions to the 2012 Commission on Cancer (CoC) cancer program standards ranged from confused to frustrated to angry to baffled. But navigators have an arsenal of tools that can help them keep the cancer programs at their institutions in adherence to the CoC standards, according to a presentation at the 2015 Oncology Nurse Advisor Navigation Summit.

Using the navigation process to improve both your program and your patient outcomes

DENVER, CO—The key to the sustainability of a navigation program is effective use of quality benchmark measures, according to a presentation at the 2015 ONA Navigation Summit. Navigators have an in-depth knowledge of evidence-based care guidelines and a unique awareness of care barriers, and can readily identify process improvement opportunities.

Transitioning High-Dose AML Chemo to Outpatient Setting Improves Quality of Life

Transitioning a long-standing intensive chemotherapy regimen for acute myeloid leukemia (AML) to the outpatient setting is safe and feasible.

Transdermal Granisetron May Be Appropriate for CINV Prevention in Lung Cancer

Granisetron transdermal system (GTS) may be appropriate for prevention of chemotherapy-induced nausea and vomiting (CINV) in lung cancer.

First Fully Integrated Oncology Emergency Department in the U.S. Launched

The James Cancer Hospital in Columbus, Ohio, has launched the first fully integrated oncology emergency department in the U.S.

Factors Affecting Women's Election to Undergo Bilateral Mastectomy Identified

Physicians and cancer survivors influence women undergoing bilateral mastectomy as their treatment for breast cancer.

Self-Management Handbook Useful for Patients with Limited English Proficiency

The feasibility for a self-management intervention handbook confirmed in Chinese American patients with cancer with limited English proficiency (LEP).

Previvorship: Managing Cancer Risk Decisions in Unaffected BRCA-positive Women

Four major themes characterize the experience of cancer risk management for women who are positive for BRCA genetic mutations.

Children's Oncology Group Examines National Educational Practices in Pediatric Patients

Premier study examines current delivery of patient/family education to pediatric patients with newly diagnosed cancer.

'Bathing and Honoring' Intervention Benefits Families After Acute Care Patient Death

Bathing and Honoring a patient who's died "provides a final positive experience for family members and allows them to begin the grieving process."

Behavioral Intervention Improves Sleep for Cancer Patient-Caregiver Dyads

A brief cognitive behavioral therapy for insomnia (CBT-I) improved sleep over 4 weeks with little to no negative effects on clinic flow.

New Instrument Assesses Caregiver Knowledge of Cancer Treatment Symptoms

Nursing Assessment of Family Caregiver Knowledge and Action Tool (NAFCKAT) may aid caregivers who need additional support.

Managing oral oncology/hematology treatments in your practice

An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.

Follow-up PET/CT more than 95% sensitive for non-Hodgkin lymphoma

BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.

Distinct triple-positive subtypes identified in breast cancer

CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.

Removing more breast tissue reduces the need for a second cancer surgery

Expanded surgical margins during a partial mastectomy could be beneficial for patients, preventing further surgery.

Next-generation ALK-inhibitor brigatinib promising against NSCLC

Clinical trial results showed good performance employing the investigational drug brigatinib against ALK-positive non-small cell lung cancer (NSCLC).

Combining targeted drug with chemotherapy prolongs life for patients with B-cell lymphoma

The combination of ibrutinib and chemotherapy (bendamustine and rituximab [BR]) was found to reduce the risk of death by nearly 80% in patients with previously treated CLL or SLL.

Immunotherapy drug improves survival for common form of lung cancer

Individuals with squamous non-small cell lung cancer (NSCLC) fared better when receiving nivolumab when compared to those receiving more standard chemotherapy, according to a recent clinical trial.

Misperceptions about impact of double mastectomy are common

Half of the women with breast cancer polled considered double mastectomy, but only a little more than a third knew the aggressive procedure doesn't up the chances of survival.

Immunotherapy combination increases progression-free survival (PFS) in advanced melanoma patients

Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.

IDH gene may serve as prognostic marker in anaplastic astrocytoma

New research indicates that the IDH1 gene might be a prognostic marker for a rare form of brain cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs